Withdrawal of Registration Statement (rw)
July 31 2017 - 8:02AM
Edgar (US Regulatory)
Nexvet Biopharma plc
Unit 5, Sragh Technology Park
Rahan Road, Tullamore
Co. Offaly,
R35 FR98, Ireland
By EDGAR
U.S. Securities and
Exchange Commission
Division of Corporation Finance
100 F
Street, N.E.
Washington, D.C. 20549-3628
|
|
|
|
|
|
|
Re:
|
|
Nexvet Biopharma public limited company
Registration Statement on
Form S-3
(File
No. 333-210876)
|
Ladies and Gentlemen:
Nexvet
Biopharma public limited company (the
Company
) hereby makes application to withdraw the Registration Statement on Form S3 originally filed by the Company with the U.S. Securities and Exchange Commission (the
Commission
) on April 22, 2016 and amended on May 3, 2016 (Registration
No. 333-210876)
(the
Registration Statement
), effective immediately.
The Registration Statement is being withdrawn because, on July 31, 2017, the Company was acquired by Zoetis Belgium S.A., a wholly-owned subsidiary of
Zoetis Inc. (the
Acquisition
) pursuant to a scheme of arrangement under Irish law. In connection with the Acquisition, the Company has determined that the Registration Statement is unnecessary and that it is in the
Companys best interest to withdraw the Registration Statement. No securities have been sold pursuant to the Registration Statement.
The Company
requests that the Commission consent to this application on the grounds that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors as contemplated by Rule 477(a) under the Securities
Act of 1933, as amended.
Please provide a copy of the order consenting to the withdrawal of the Registration Statement to Andrew Ledbetter of DLA Piper
LLP (US) (
DLA Piper
), counsel to the Company, via email at
andrew.ledbetter@dlapiper.com
or via facsimile at
206-494-1800.
If you have any
questions with respect to this matter, please contact Andrew Ledbetter of DLA Piper at (206)
839-4845.
|
|
|
Sincerely,
Nexvet Biopharma public limited company
|
|
|
By:
|
|
/s/ Damian Lismore
|
Name:
|
|
Damian Lismore
|
Title:
|
|
Authorized officer
|
cc: Andrew Ledbetter (DLA Piper)
NEXVET BIOPHARMA PLC (NASDAQ:NVET)
Historical Stock Chart
From Aug 2024 to Sep 2024
NEXVET BIOPHARMA PLC (NASDAQ:NVET)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Nexvet Biopharma Plc - Ordinary Shares (NASDAQ): 0 recent articles
More Nexvet Biopharma Plc News Articles